José D. González

3.1k total citations
18 papers, 1.6k citations indexed

About

José D. González is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, José D. González has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in José D. González's work include Retinoids in leukemia and cellular processes (11 papers), Acute Myeloid Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (4 papers). José D. González is often cited by papers focused on Retinoids in leukemia and cellular processes (11 papers), Acute Myeloid Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (4 papers). José D. González collaborates with scholars based in Spain, Argentina and Netherlands. José D. González's co-authors include Miguel Á. Sanz, Joaquı́n Dı́az-Mediavilla, Marcos González, Jordi Esteve, Juan Bergua, Javier de la Serna, Pau Montesinos, Giuseppe Milone, Concha Rivas and Bob Löwenberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Emergency Medicine.

In The Last Decade

José D. González

16 papers receiving 1.5k citations

Peers

Countries citing papers authored by José D. González

Since Specialization

Citations

This map shows the geographic impact of José D. González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José D. González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José D. González more than expected).

Fields of papers citing papers by José D. González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José D. González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José D. González. The network helps show where José D. González may publish in the future.

Co-authorship network of co-authors of José D. González

This figure shows the co-authorship network connecting the top 25 collaborators of José D. González. A scholar is included among the top collaborators of José D. González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José D. González. José D. González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Reacciones adversas a medicamentos utilizados para la COVID-19 en cinco países de América Latina 2022 ·Revista Panamericana de Salud Pública ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Diego Gutiérrez, (unknown), José D. González, Analı́a Porrás, José L. Castro	1
2	Barreras para la prevención y detección temprana de cáncer de cuello uterino 2017 ·Investigación en Enfermería Imagen y Desarrollo ·(unknown), (unknown), José D. González, (unknown), (unknown), (unknown)	15
3	Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia 2015 ·Annals of Hematology ·Miguel Á. Sanz, Pau Montesinos, (unknown), Joaquı́n Dı́az-Mediavilla, Santiago Jiménez, (unknown), Pascual Fernández, José González‐Campos, José D. González, Pilar Herrera, Elena de Lisa, (unknown), Rafael Rojas, Olga Salamero, María José Sayas, António Pellicer, Alfredo Perales	11
4	Bortezomib-based induction therapy followed by intravenous busulfan–melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma 2014 ·Leukemia & lymphoma ·Margarita Blanes, José D. González, Juan José Lahuerta, Paz Ribas, Ignacio Lorenzo, Blanca Boluda, Miguel Á. Sanz, Javier de la Rubia	6
5	Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach 2012 ·Biology of Blood and Marrow Transplantation ·Margarita Blanes, Juan José Lahuerta, José D. González, Paz Ribas, Carlos Solano, Adrían Alegre, Joan Bladé, Jesús F. San Miguel, Miguel Á. Sanz, Javier de la Rubia	49
6	Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy 2010 ·Journal of Clinical Oncology ·Pau Montesinos, José D. González, José González, Chelo Rayón, Elena de Lisa, María Luz Amigo, Gert J. Ossenkoppele, María Jesús Peñarrubia, Manuel Pérez‐Encinas, Juan Bergua, Guillermo Debén, María José Sayas, Javier de la Serna, Josep‐María Ribera, Javier Bueno, Giuseppe Milone, Concha Rivas, Salut Brunet, Bob Löwenberg, Miguel Á. Sanz	49
7	Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome 2010 ·Blood ·Miguel Á. Sanz, Pau Montesinos, Chelo Rayón, (unknown), Javier de la Serna, Giuseppe Milone, Elena de Lisa, Salut Brunet, Vicente Rubio, Josep‐María Ribera, Concha Rivas, Isabel Krsnik, Juan Bergua, José González, Joaquı́n Dı́az-Mediavilla, Rafael Rojas, F. Manso, Gert J. Ossenkoppele, José D. González, Bob Löwenberg	204
8	Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial 2009 ·Leukemia & lymphoma ·Margarita Blanes, Javier de la Rubia, Juan José Lahuerta, José D. González, Paz Ribas, Carlos Solano, Adrían Alegre, Miguel Á. Sanz	17
9	Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors 2008 ·Blood ·Pau Montesinos, Juan Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Javier de la Serna, Ángel León, Jordi Esteve, Giuseppe Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquı́n Dı́az-Mediavilla, José D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Löwenberg, Miguel Á. Sanz	233
10	Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin 2008 ·Blood ·Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody, Ángel León, Jordi Esteve, Juan Bergua, Giuseppe Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquı́n Dı́az-Mediavilla, José D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Löwenberg, Miguel Á. Sanz	246
11	A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma 2008 ·Blood ·Laura Rosiñol, Josè Antonio Pérez-Simón, Anna Sureda, Javier de la Rubia, Felipe de Arriba, Juan José Lahuerta, José D. González, Joaquı́n Dı́az-Mediavilla, Belén Hernández, Javier García‐Frade, Dolores Carrera, Ángel León, Miguel‐Teodoro Hernández, Pascual Fernández, Juan Bergua, Jesús F. San Miguel, Joan Bladé	172
12	Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients 2008 ·Blood ·Miguel Á. Sanz, Pau Montesinos, (unknown), Giuseppe Milone, Chelo Rayón, Elena de Lisa, Javier de la Serna, Salut Brunet, Ángel León, Isabel Krsnik, Concha Rivas, Josep‐María Ribera, José D. González, Joaquín Díaz Mediavilla, Javier Bueno, Juan Bergua, Marcos González	0
13	Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All- Trans Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia 2008 ·Blood ·Pau Montesinos, Edo Vellenga, (unknown), Chelo Rayón, Giuseppe Milone, Javier de la Serna, Ángel León, Juan Bergua, Concha Rivas, José D. González, Jordi Esteve, Miguel Á. Sanz, (unknown)	5
14	Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia. 2007 ·Blood ·Pau Montesinos, José D. González, Chelo Rayón, Javier de la Serna, Juan Bergua, Jordi Esteve, Mar Tormo, Edo Vellenga, Elena Amutio, Guillermo Debén, Miguel Á. Sanz	1
15	Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Reinforced Anthracycline Monochemotherapy. 2007 ·Blood ·Pau Montesinos, José D. González, Edo Vellenga, Chelo Rayón, Ricardo Parody, Ángel León, Jordi Esteve, Juan Bergua, Giuseppe Milone, Miguel Á. Sanz	1
16	Treatment With All-Trans Retinoic Acid and Anthracycline Monochemotherapy for Children With Acute Promyelocytic Leukemia: A Multicenter Study by the PETHEMA Group 2005 ·Journal of Clinical Oncology ·Juan Ortega, Luís Madero, Guillermo Martı́n, Amparo Verdeguer, (unknown), Ricardo Parody, José Luís Fuster, Antonio Molinés, Andrés Novo, Guillermo Debén, Antonia Rodríguez, Eulogio Conde, Javier de la Serna, (unknown), Francisco Capote, José D. González, Pascual Bolufer, Marcos González, Miguel Á. Sanz	89
17	Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. 2000 ·PubMed ·Miguel Á. Sanz, (unknown), Guillermo Martı́n, Giuseppe Avvisati, Consuelo Rayón, Tiziano Barbui, Joaquı́n Dı́az-Mediavilla, Giuseppe Fioritoni, José D. González, Vincenzo Liso, Jordi Esteve, Felicetto Ferrara, Pascual Bolufer, Carlo Bernasconi, Marcos González, Francesco Rodeghiero, Dolors Colomer, Maria Concetta Petti, Josep‐María Ribera, Franco Mandelli	449
18	Self-treatment with antibiotics 1987 ·Annals of Emergency Medicine ·Mark S. Puczynski, José D. González, J. Paul O'Keefe	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact